Structure Therapeutics Inc.
GPCR
$19.61
$0.241.24%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -31.66% | -28.38% | -7.36% | -30.51% | 0.01% |
| Total Depreciation and Amortization | 6.20% | 3.01% | -3.62% | 18.97% | 4.50% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 229.13% | 304.64% | -7.28% | -79.07% | 1,618.95% |
| Change in Net Operating Assets | 145.32% | -1,173.97% | -103.90% | 773.70% | 75.11% |
| Cash from Operations | -4.46% | -43.22% | -85.15% | 25.37% | 22.56% |
| Capital Expenditure | 26.11% | -1,862.50% | 97.66% | -60.42% | -163.58% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 43.17% | 3.31% | 117.65% | 7.71% | -13,016.96% |
| Cash from Investing | 43.81% | 2.41% | 117.58% | 7.56% | -14,522.78% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -46.42% | 56.91% | 54.91% | -99.92% | 68,150.60% |
| Repurchase of Common Stock | 100.00% | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 100.00% | -95.93% | -1,011.32% |
| Cash from Financing | -36.09% | 31.54% | 181.24% | -100.15% | 73,219.52% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 70.67% | -563.63% | 98.75% | -173.82% | 987.97% |